Bilkent University National Nanotechnology Research Center’s (UNAM) Dr. Urartu Özgür Safak Şeker and his graduate students Recep Erdem Ahan, Doğuş Akboğa, Derin Akman, Damla Albayrak, Ece Avcı, Mehmet Emin Bakar, Aslı Doğruer, Ahmet Hınçer, Melis Karaca, Fayit Purkat, Aslı Semerci, Gozeel Binte Shahid, Senem Şen, Nazlıcan Tunç, and Merve Yavuz have published a new book entitled “Synthetic Biology for Therapeutics: Engineering Cells for Living Drugs.” The book focuses on how synthetic biology can be applied to the development of new cancer therapies, particularly through the use of engineered genetic circuits within cells.
Dr. Şeker’s work explores the potential of cellular therapies, including microbial therapies and CAR-T cell therapies, as alternatives to traditional cancer treatments. It covers the engineering of mammalian and microbial cells to deliver targeted therapies as well as the development of biological devices for precise cellular targeting.
The book is intended for scientists and researchers in biotechnology, medicine and synthetic biology, providing insights into how the genetic engineering of cells can be used to create living drugs for the treatment of cancer and other diseases.
